J&J backs out of RSV vaccine race with rivals Pfizer and GSK

J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month.

from Health and Science https://ift.tt/NkOA35T
https://ift.tt/NjwXqId
https://ift.tt/sk0gnXc